Barclays’s Usana Health Sciences USNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2013
Q4
– Sell
-17,400
Closed -$748K – 7694
2013
Q3
$748K Sell
17,400
-7,400
-30% -$297K ﹤0.01% 3668
2013
Q2
$898K Buy
+24,800
New +$754K ﹤0.01% 3526

Other funds holding USNA

Barclays's USNA Position: Q3 2026 in Review

Barclays increased its Usana Health Sciences (USNA) stake by 209% in Q3 2026, buying an estimated $1.31M and bringing the position to 112,326 shares worth $1.63M. The position accounts for ﹤0.01% of the portfolio, ranked #2731.

Barclays first reported a position in USNA in Q2 2013 and has held it in 54 quarters since. The position peaked at $3.85M in Q2 2014. 128 funds tracked by Wall St. Rank hold USNA as of Q3 2026.

  • Barclays held 112,326 shares of Usana Health Sciences worth $1.63M as of Q3 2026.
  • Barclays bought 75,926 Usana Health Sciences shares in Q3 2026, an estimated $1.31M.
  • Usana Health Sciences made up ﹤0.01% of Barclays's portfolio in Q3 2026, its #2731 holding.
  • Barclays first reported a position in Usana Health Sciences in Q2 2013 and has held it in 54 quarters since.
  • Barclays's Usana Health Sciences position peaked at $3.85M in Q2 2014.
  • 128 funds tracked by Wall St. Rank held Usana Health Sciences as of Q3 2026.

Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.